A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert C. Alexander, MD
AstraZeneca Research & Development, Neuroscience iMed, 141 Portland Street, Cambridge, MA 02139
Study Director - Roza Hayduk, MD
Quintiles 10201 Wateridge Circle San Diego, CA
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Phoenix, Arizona, United States
- Research Site
Indio, California, United States
- Research Site
Lomita, California, United States
- Research Site
San Francisco, California, United States
- Research Site
Delray Beach, Florida, United States
- Research Site
Fort Myers, Florida, United States
- Research Site
Hallandale, Florida, United States
- Research Site
Orlando, Florida, United States
- Research Site
Tampa, Florida, United States
- Research Site
Eatontown, New Jersey, United States
- Research Site
Brooklyn, New York, United States
- Research Site
New York, New York, United States
- Research Site
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2012
- Primary completion
- 31 Jan 2013
- Completion
- 31 Jan 2013
- Last update posted
- 7 Feb 2017
- Registered enrollment
- 164
- Registry id
- NCT01548287
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.